BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25091658)

  • 1. [Carcinosarcomas in female genital tracts: general review].
    Guy JB; Trone JC; Casteillo F; Forest F; Pacaut C; Moncharmont C; Espenel S; Vallard A; Langrand Escure J; Collard O; Peoc'h M; Magné N
    Bull Cancer; 2014; 101(7-8):760-4. PubMed ID: 25091658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 12 cases of uterine carcinosarcoma].
    Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
    Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
    Gupta N; Dudding N; Smith JH
    Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Melanomas of the female genital tract: state of the art].
    Trone JC; Guy JB; Mery B; Langrand Escure J; Lahmar R; Moncharmont C; Rivoirard R; Semay T; Chauleur C; Collard O; Vignot S; Magné N
    Bull Cancer; 2014 Jan; 101(1):102-6. PubMed ID: 24445910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
    Costa MJ; Khan R; Judd R
    Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine carcinosarcoma.
    Arend R; Doneza JA; Wright JD
    Curr Opin Oncol; 2011 Sep; 23(5):531-6. PubMed ID: 21743326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review literature on uterine carcinosarcoma.
    Singh R
    J Cancer Res Ther; 2014; 10(3):461-8. PubMed ID: 25313723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
    Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
    Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical carcinosarcoma: a case report.
    Abidi A; Menn K; Sherman A; Konia T; Azodi M
    J Reprod Med; 2008 Feb; 53(2):138-40. PubMed ID: 18357808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mixed müllerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary: Report of a case with clinicopathologic findings.
    Matsuura Y; Kitajima M; Hachisuga T; Tanimoto A; Okura N; Kihara I
    J Obstet Gynaecol Res; 2010 Aug; 36(4):907-11. PubMed ID: 20666968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant tumors of the genitalia in girls].
    Bokhman IaV; Nechaeva ID; Maksimov SIa; Kutusheva GF; Kolygin BA
    Vopr Onkol; 1986; 32(1):74-80. PubMed ID: 3511609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
    Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
    Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma.
    Kahramanoglu I; Demirkiran F; Turan H; Bese T; Cebi S; Ilvan S; Arvas M
    J Obstet Gynaecol Can; 2021 Jan; 43(1):34-42. PubMed ID: 33041218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral ovarian malignant mixed Mullerian tumor in a dog.
    Antuofermo E; Cocco R; Borzacchiello G; Burrai GP; Meloni F; Bonelli P; Pirino S; Cossu-Rocca P; Bosincu L
    Vet Pathol; 2009 May; 46(3):453-6. PubMed ID: 19176505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecological sarcomas.
    DiSaia PJ; Pecorelli S
    Semin Surg Oncol; 1994; 10(5):369-73. PubMed ID: 7997731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrence of gynecologic malignancies after combined and primary radiotherapy. Incidence and lapse of time until the diagnosis is made].
    Csaicsich P; Tatra G; Michalica W
    Strahlenther Onkol; 1986 Jul; 162(7):409-13. PubMed ID: 3738739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.